Market Place
Sourcing Support
Amneal’s Generics Eltrombopag Olamine Receives Approval in US
14 Jan 2026 //
FDA
Zyd Pharms’ Generics Eltrombopag Olamine Receives Approval in US
14 Jan 2026 //
FDA
Ascent Pharms’ Generics Topiramate Receives Approval in US
12 Jan 2026 //
FDA
Respirent’ Generics Fluticasone Propionate Receive Approval in US
12 Jan 2026 //
FDA
Sentynl Theraps’ Zycubo Receives Approval in US
12 Jan 2026 //
FDA
Umedica’s Generics Varenicline Tartrate Receives Approval in US
09 Jan 2026 //
FDA
Biocon Pharma’s Generics Everolimus Receives Approval in US
09 Jan 2026 //
FDA
Torrent’s Generics Lamotrigine Receives Approval in US
08 Jan 2026 //
FDA
Micro’s Generics Sapropterin 2HCl Receives Approval in US
08 Jan 2026 //
FDA
ScieGen’s Generics Dapagliflozin Receive Tentative Approval in US
08 Jan 2026 //
FDA
Micro’s Generics Furosemide Receives Approval in US
08 Jan 2026 //
FDA
Aurobindo’s Generics Phenylbutyrate Receives Approval in US
07 Jan 2026 //
FDA
Granules’s Generics Amphetamine Receives Tentative Approval in US
07 Jan 2026 //
FDA
Bpi’s Generics Selenious Acid Receives Tentative Approval in US
07 Jan 2026 //
FDA
Mylan’s Generics Rifaximin Receives Tentative Approval in US
07 Jan 2026 //
FDA
Hebei Changshan’s Generics Enoxaparin Na Receives Approval in US
07 Jan 2026 //
FDA
Humanwell’s Generics Nintedanib Receives Tentative Approval in US
07 Jan 2026 //
FDA
Gland’s Generics Bortezomib Receives Approval in US
06 Jan 2026 //
FDA
Upsher Smith’s Generics Ciprofloxacin Receives Approval in US
06 Jan 2026 //
FDA
Gland’s Generics Olopatadine HCl Receives Approval in US
06 Jan 2026 //
FDA
Knack’s Generics Rocuronium Bromide Receives Approval in US
06 Jan 2026 //
FDA
Mankind’s Generics Extended Phenytoin Na Receives Approval In US
02 Jan 2026 //
FDA
Taro’s Generics Acetaminophen & Ibuprofen Receives Approval in US
02 Jan 2026 //
FDA
Alkem’s Generics Dapagliflozin Receives Tentative Approval in US
02 Jan 2026 //
FDA
Hansoh’s Generics Dapagliflozin Receives Tentative Approval in US
23 Dec 2025 //
FDA
Novo Nordisk’s Wegovy Receives Approval in US
22 Dec 2025 //
FDA
RB Hlth’s Mucinex Receives Approval in US
22 Dec 2025 //
FDA
Amneal Pharms’ Biologics Oziltus Receives Approval in US
19 Dec 2025 //
FDA
Amneal Pharms’ Biologics Boncresa Receives Approval in US
19 Dec 2025 //
FDA
Boehringer Ingelheim Pharma’s Jascayd Receives Approval in US
19 Dec 2025 //
FDA
Cytokinetics’ Myqorzo Receives Approval in US
19 Dec 2025 //
FDA
Formyn AG’s Biologics Nufymco Receives Approval in US
18 Dec 2025 //
FDA
Creekwood Pharms’ Generics Haloperidol Receives Approval in US
18 Dec 2025 //
FDA
Teva’ Generics Dapagliflozin Receives Tentative Approval in US
18 Dec 2025 //
FDA
Micro’s Generics Tenofovir Disoproxil Receives Approval in US
18 Dec 2025 //
FDA
Janssen’s Biologics Rybrevant Faspro Receives Approval in US
17 Dec 2025 //
FDA
Mankind Pharma’s Generics Latanoprost Receives Approval in US
17 Dec 2025 //
FDA
Shuangcheng’s Generics Bortezomib Receives Approval in US
17 Dec 2025 //
FDA
Alembic’s Generics Travoprost Receives Approval in US
17 Dec 2025 //
FDA
Glaxosmithkline’s Biologics Exdensur Receives Approval in US
16 Dec 2025 //
FDA
Novitium’s Generics Hydroxyzine HCl Receives Approval in US
16 Dec 2025 //
FDA
Amneal Ireland’s Generics Beclomethasone Receives Approval in US
16 Dec 2025 //
FDA
Aurobindo Pharma’s Generics Cariprazine Receives Approval in US
16 Dec 2025 //
FDA
Ibsa Inst Bio’s Vybrique Receives Approval in US
16 Dec 2025 //
FDA
Ascent’ Generics Buprenorphine & Naloxone Receives Approval in US
15 Dec 2025 //
FDA
Lib ,’s Biologics Lerochol Receives Approval in US
12 Dec 2025 //
FDA
Entasis Therap’s Nuzolvence Receives Approval in US
12 Dec 2025 //
FDA
Milestone Pharma ,’s Cardamyst Receives Approval in US
12 Dec 2025 //
FDA
Amneal’s Generics Deflazacort Receives Approval in US
12 Dec 2025 //
FDA
Mylan’s Generics Octreotide Acetate Receives Approval in US
12 Dec 2025 //
FDA
Amphastar Pharms’ Generics Teriparatide Receives Approval in US
12 Dec 2025 //
FDA
LNK’s Generics Acetaminophen & Ibuprofen Receives Approval in US
11 Dec 2025 //
FDA
MSN’s Generics Norepinephrine Bitartrate Receives Approval in US
11 Dec 2025 //
FDA
Senores Pharms’ Generics Deferiprone Receives Approval in US
11 Dec 2025 //
FDA
Acadia Pharms’ Daybue Stix Receives Approval in US
11 Dec 2025 //
FDA
Biocryst Pharma,’s Orladeyo Receives Approval in US
11 Dec 2025 //
FDA
Micro’s Generics Lopinavir And Ritonavir Receives Approval in US
11 Dec 2025 //
FDA
Novitium Pharma’s Generics Omeprazole Receives Approval in US
10 Dec 2025 //
FDA
Specgx’s Generics Buprenorphine HCl Receives Approval in US
10 Dec 2025 //
FDA
Alembic’s Generics Loteprednol Etabonate Receives Approval in US
10 Dec 2025 //
FDA
